EVERY TRAUMATIC
BRAIN INJURY IS UNIQUE.

YOUR TREATMENT SHOULD BE TOO.


Welcome to the TBI Monitoring Program (TMP) at Kaizen Brain Center, where we provide comprehensive care for patients with Traumatic Brain Injury (TBI) and Concussions. Our program is designed to closely monitor patients over a period of time to understand the progression of their TBI and detect early signs of neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and Chronic Traumatic Encephalopathy (CTE).

TBI can range in severity from mild to severe, based on the length of changes in consciousness, brain bleeding, and other neurological symptoms. The most common form of TBI is mild, also known as a concussion, which typically results in symptoms such as headache, vision changes, and dizziness lasting for 10-14 days. We call this a neurological event, which usually resolves with minimal intervention.

However, in about 40% of people, initial symptoms persist and may evolve to include mood and cognitive difficulties. This is referred to as Post Concussive Syndrome (PCS) and requires more focused interventions for prolonged symptom management. If left untreated, PCS can have a significant impact on day-to-day functionality and may result in disability.

Additionally, TBI is a risk factor for developing progressive neurological conditions such as Alzheimer’s disease, Parkinson’s disease, and CTE, which can lead to the loss of brain cells over time. Our TBI Monitoring Program was created to closely follow patients at risk of these disorders and detect early signs of their development.

At Kaizen Brain Center, we understand that not every patient with TBI requires enrollment in the TBI Monitoring Program. Patients are initially assessed by our TBI team, and we decide to transition them to our program based on their clinical findings. We also provide second opinions for patients with an established diagnosis of TBI who are seeking an alternative perspective.

Program Goals

  • Detect early signs of Alzheimer’s disease, Parkinson’s disease, and CTE to provide early intervention and develop personalized treatment plans
  • Improve the patient’s quality of life and slow down the progression of any neurodegenerative disorder that may develop due to their TBI.